샘플 요청 목록

 카트 문의
시장보고서
상품코드
1791610

세계의 시토신 시장

Cytosine
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 186 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 시토신 시장은 2030년까지 5억 9,530만 달러에 이를 전망

2024년에 3억 6,260만 달러로 추정되는 시토신 세계 시장은 분석 기간인 2024-2030년 CAGR 8.6%로 성장하여 2030년에는 5억 9,530만 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 의약품 최종 사용은 CAGR 9.8%를 나타내고, 분석 기간 종료시에는 3억 130만 달러에 이를 것으로 예측됩니다. 농업용 최종 사용 부문의 성장률은 분석 기간중 CAGR 8.2%로 추정됩니다.

미국 시장은 9,880만 달러로 추정, 중국은 CAGR 13.6%로 성장 예측

미국의 시토신 시장은 2024년에 9,880만 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 1억 3,070만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 13.6%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 4.3%와 8.3%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 5.8%를 보일 전망입니다.

세계의 시토신 시장 - 주요 동향과 시장 성장 촉진요인 정리

시토신은 왜 생명공학 및 제약 분야에서 점점 더 중요해지고 있는가?

시토신은 질소 염기이며 DNA와 RNA의 필수 성분으로 유전자 연구, 의약품 개발, 생명공학 응용에 중요한 역할을 합니다. 항바이러스제 및 항암제 제조에 사용되는 뉴클레오시드 아날로그의 주요 전구체 역할을 합니다. 유전자 치료, 맞춤의료, 분자진단에 대한 관심이 높아지면서 의약품 개발 및 유전공학 분야에서 시토신 기반 화합물에 대한 수요가 증가하고 있습니다.

합성생물학과 CRISPR 기반 유전자 편집의 부상은 시토신의 용도를 더욱 확대했습니다. 과학자들은 시토신의 변형을 활용하여 유전질환, 자가면역질환, 표적 암 치료를 위한 첨단 치료제를 개발하고 있습니다. 또한, 시토신 유도체는 새로운 RNA 기반 백신을 위해 연구되고 있으며, 백신 기술의 발전에 기여하고 있습니다.

시토신 연구의 최신 기술 발전은 무엇인가?

시토신 관련 연구에서 가장 중요한 진전 중 하나는 CRISPR-Cas9과 염기교정 기술의 개발입니다. 시토신 염기편집기(CBE)는 시토신을 티민으로 변환하여 정확한 유전자 변형을 가능하게 함으로써 유전자 변이를 교정하는 획기적인 접근법을 제공합니다. 이러한 기술 혁신은 유전 의학에 혁명을 가져왔고, 유전성 질환과 희귀 유전 질환을 대상으로 한 치료법의 길을 열었습니다.

또 다른 주요 발전은 항바이러스 및 면역 요법에 적용하기 위한 시토신 유사체의 합성입니다. 제약 연구자들은 약물의 안정성, 생체 이용률, 약제 내성 바이러스에 대한 효능을 높이기 위해 변형된 시토신 분자를 공학적으로 연구하고 있습니다. AI를 활용한 신약개발 플랫폼도 시토신 기반 화합물 스크리닝을 가속화하여 차세대 뉴클레오시드 치료제 개발을 효율화하고 있습니다.

시장 동향과 규제 지침이 시토신 채택에 어떤 영향을 미치고 있는가?

시장 동향은 핵산 기반 치료에 대한 관심이 높아지면서 고순도 시토신 유도체에 대한 수요를 촉진하고 있습니다. RNA 치료제의 급속한 발전, 특히 mRNA 백신의 성공은 생물 의학 혁신에서 시토신의 역할을 더욱 부각시키고 있습니다. 또한, 유전자 연구 및 정밀의료 이니셔티브에 대한 자금 지원이 증가함에 따라 의약품 연구 및 개발에 시토신 기반 기술의 채택이 가속화되고 있습니다.

미국 FDA와 유럽의약품청(EMA) 등 규제기관은 안전성과 유효성을 보장하기 위해 핵산 기반 치료법을 엄격하게 모니터링하고 있습니다. 엄격한 품질 관리와 GMP(Good Manufacturing Practice) 가이드라인 준수는 시토신 제조업체들이 고순도 제조 공정에 투자하도록 유도하고 있습니다. 또한, 유전자 편집과 합성생물학을 둘러싼 윤리적 고려가 규제 상황을 형성하고 시장 개척에 영향을 미치고 있습니다.

시토신 시장 성장의 원동력은?

시토신 시장 성장의 원동력은 유전자 치료, 분자진단, 항바이러스제 개발 분야의 확대입니다. 유전성 질환과 감염성 질환의 확산이 증가함에 따라, 특히 종양학 및 바이러스학 분야에서 시토신 기반 치료제에 대한 요구가 증가하고 있습니다.

최종 용도의 확대도 중요한 요인 중 하나이며, 시토신은 생명공학 연구, 법의학, 농업유전체학에 널리 활용되고 있습니다. DNA 기반 데이터 저장 기술의 출현도 시장 확대에 기여하고 있으며, 연구자들은 고밀도 정보 저장에 대한 시토신의 가능성을 탐구하고 있습니다. 또한, 생명공학 기업, 제약회사, 학술기관의 협업으로 시토신 관련 신약개발과 유전공학의 혁신을 촉진하고 있습니다. 유전체학 및 정밀의료의 발전과 함께 시토신 시장은 지속적인 성장세를 보이며 유전자 연구 및 치료제 개발의 미래를 형성할 것으로 예측됩니다.

부문

최종사용자(의약품 최종사용자, 농업 최종사용자, 화학 산업 최종사용자, 기타 최종사용자)

조사 대상 기업 예

  • Acros Organics
  • AK Scientific, Inc.
  • Alfa Aesar, Thermo Fisher Scientific
  • Apollo Scientific Ltd.
  • BOC Sciences
  • Carbosynth Ltd.
  • Central Drug House(CDH)
  • Chem-Impex International, Inc.
  • FUJIFILM Wako Pure Chemical Corporation
  • GLPBIO Technology LLC
  • KANTO CHEMICAL CO., INC.
  • LGC Standards
  • MedChemExpress
  • MilliporeSigma
  • Santa Cruz Biotechnology, Inc.
  • Selleck Chemicals
  • SIELC Technologies
  • Spectrum Chemical Manufacturing Corp.
  • Tokyo Chemical Industry Co., Ltd.
  • Toronto Research Chemicals

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장과 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.21

Global Cytosine Market to Reach US$595.3 Million by 2030

The global market for Cytosine estimated at US$362.6 Million in the year 2024, is expected to reach US$595.3 Million by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. Pharmaceutical End-Use, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$301.3 Million by the end of the analysis period. Growth in the Agriculture End-Use segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$98.8 Million While China is Forecast to Grow at 13.6% CAGR

The Cytosine market in the U.S. is estimated at US$98.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$130.7 Million by the year 2030 trailing a CAGR of 13.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 8.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Cytosine Market - Key Trends & Growth Drivers Summarized

Why Is Cytosine Gaining Significance in Biotechnology and Pharmaceuticals?

Cytosine, a nitrogenous base and an essential component of DNA and RNA, plays a vital role in genetic research, pharmaceutical development, and biotechnology applications. It serves as a key precursor in nucleoside analogs used for antiviral and anticancer drug formulations. The increasing focus on gene therapy, personalized medicine, and molecular diagnostics has elevated the demand for cytosine-based compounds in drug development and genetic engineering.

The rise of synthetic biology and CRISPR-based genome editing has further expanded cytosine’s applications. Scientists are leveraging cytosine modifications to develop advanced therapeutics for genetic disorders, autoimmune diseases, and targeted cancer treatments. Additionally, cytosine derivatives are being explored for novel RNA-based vaccines, contributing to advancements in vaccine technology.

What Are the Latest Technological Advancements in Cytosine Research?

One of the most significant advancements in cytosine-related research is the development of CRISPR-Cas9 and base editing technologies. Cytosine base editors (CBEs) enable precise genetic modifications by converting cytosine to thymine, offering a groundbreaking approach to correcting genetic mutations. These innovations have revolutionized genetic medicine, paving the way for therapies targeting inherited diseases and rare genetic disorders.

Another key development is the synthesis of cytosine analogs for antiviral and immunotherapy applications. Pharmaceutical researchers are engineering modified cytosine molecules to enhance drug stability, bioavailability, and efficacy against drug-resistant viruses. AI-driven drug discovery platforms are also accelerating cytosine-based compound screening, streamlining the development of next-generation nucleoside therapeutics.

How Are Market Trends and Regulatory Guidelines Influencing Cytosine Adoption?

Market trends indicate a growing interest in nucleic acid-based therapies, driving the demand for high-purity cytosine derivatives. The rapid advancements in RNA therapeutics, particularly with the success of mRNA vaccines, have further highlighted cytosine’s role in biomedical innovation. Additionally, increased funding for genetic research and precision medicine initiatives is accelerating the adoption of cytosine-based technologies in pharmaceutical R&D.

Regulatory agencies, including the U.S. FDA and the European Medicines Agency (EMA), are closely monitoring nucleic acid-based therapies to ensure safety and efficacy. Compliance with stringent quality control and Good Manufacturing Practice (GMP) guidelines has encouraged cytosine manufacturers to invest in high-purity production processes. Additionally, ethical considerations surrounding gene editing and synthetic biology are shaping the regulatory landscape, influencing market development.

What Is Driving the Growth of the Cytosine Market?

The growth in the cytosine market is driven by the expanding fields of gene therapy, molecular diagnostics, and antiviral drug development. The increasing prevalence of genetic diseases and infectious disorders has fueled the need for cytosine-based therapeutics, particularly in oncology and virology.

End-use expansion is another critical factor, with cytosine being widely utilized in biotechnology research, forensic science, and agricultural genomics. The emergence of DNA-based data storage technologies is also contributing to market expansion, as researchers explore cytosine’s potential in high-density information storage. Additionally, collaborations between biotech firms, pharmaceutical companies, and academic institutions are fostering innovation in cytosine-related drug discovery and genetic engineering. As advancements in genomics and precision medicine continue, the cytosine market is expected to experience sustained growth, shaping the future of genetic research and therapeutic development.

SCOPE OF STUDY:

The report analyzes the Cytosine market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Acros Organics
  • AK Scientific, Inc.
  • Alfa Aesar, Thermo Fisher Scientific
  • Apollo Scientific Ltd.
  • BOC Sciences
  • Carbosynth Ltd.
  • Central Drug House (CDH)
  • Chem-Impex International, Inc.
  • FUJIFILM Wako Pure Chemical Corporation
  • GLPBIO Technology LLC
  • KANTO CHEMICAL CO., INC.
  • LGC Standards
  • MedChemExpress
  • MilliporeSigma
  • Santa Cruz Biotechnology, Inc.
  • Selleck Chemicals
  • SIELC Technologies
  • Spectrum Chemical Manufacturing Corp.
  • Tokyo Chemical Industry Co., Ltd.
  • Toronto Research Chemicals

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Cytosine - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Cytosine as a Key Building Block in Nucleic Acid Synthesis
    • Expansion of mRNA and DNA-Based Therapeutics Driving Raw Material Usage
    • Increased Application in Cancer Research and Antiviral Drug Development
    • Rising Use in Genetic Engineering and Synthetic Biology Accelerating Demand
    • Emergence of Gene Editing Tools Requiring Nucleotide Supply Chain Security
    • Technological Advances in High-Purity Cytosine Manufacturing Enhancing Availability
    • Use in Academic and Industrial Research Supporting Consumable Growth
    • Integration in CRISPR-Related Processes Fueling Market Opportunities
    • Growth in Personalized and Precision Medicine Expanding Nucleic Acid Needs
    • Rising Demand for Stable Cytosine Derivatives in Pharmaceutical Formulations
    • Expansion of Biotech Startups and CDMOs Driving Bulk Procurement
    • Growing Role in Oligonucleotide Synthesis for Diagnostic and Therapeutic Uses
    • Increased Investment in RNA-Based Vaccines and Drug Pipelines Boosting Demand
    • Use in Agricultural Genomics and Seed Trait Engineering Supporting Diversification
    • Supply Chain Localization Initiatives Supporting Cytosine Production Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cytosine Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cytosine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cytosine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cytosine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pharmaceutical End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pharmaceutical End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Pharmaceutical End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Agriculture End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Agriculture End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Agriculture End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Chemical Industry End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Chemical Industry End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Chemical Industry End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cytosine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Canada 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Cytosine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Japan 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Cytosine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: China 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Cytosine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Cytosine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Cytosine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Cytosine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Cytosine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: France 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Cytosine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Germany 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Italy 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cytosine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: UK 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Spain 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Russia 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of Europe 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cytosine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Cytosine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Cytosine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Cytosine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cytosine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Australia 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Cytosine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: India 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: South Korea 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cytosine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Cytosine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Cytosine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Cytosine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Argentina 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Brazil 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Mexico 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Latin America 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cytosine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Cytosine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Cytosine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Cytosine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Iran 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Israel 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Saudi Arabia 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: UAE 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Middle East 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Cytosine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Cytosine by End-Use - Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Africa 15-Year Perspective for Cytosine by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical End-Use, Agriculture End-Use, Chemical Industry End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제